Cancer Protein Description
This report provides a detailed description of a selected cancer protein with information collected from various sources, including UniProt, the Wellcome Trust Sanger Institute’s Catalogue of Somatic Mutations in Cancer (COSMIC), and the Atlas of Genetics and Cytogenetics in Oncology and Haematology.
| Protein Name: | CdkL2 |
| Gene Name: | CDKL2 |
| Protein Full Name: | Cyclin-dependent kinase-like 2 |
| Alias: | EC 2.7.11.22; Kinase CdkL2; KKIAMRE; P56; Protein kinase p56 KKIAMRE; Serine/threonine-protein kinase KKIAMRE |
| Mass (Da): | 56019 |
| Number AA: | 493 |
| UniProt ID: | Q92772 |
| Locus ID: | 8999 |
| COSMIC ID: | CDKL2 |
| Gene location on chromosome: | 4q21.1 |
| Cancer protein type: | UNCLEAR |
| Effect of cancer mutation on protein: | UNCLEAR |
| Effect of active protein on cancer: | UNCLEAR |
| Number of cancer specimens: | 19948 |
| Percent of cancer specimens with mutations: | 0.54 |
| Normal role description: | CDKL2 is a protein-serine/threonine kinase. Its expression is increased when stimulated with epidermal growth factor. It may play a role in signal transduction and differentiation. It has been found to have a role in memory and learning. |